SARS-CoV-2 is a potential cause of Guillain-Barré syndrome
the verdict
SUPPORTED
the evidence backs this
confidence 75/100
Multiple clinical reports and studies support the conclusion that SARS-CoV-2 infection can trigger Guillain-Barré syndrome as an immune-mediated neurological complication.
Evidence for · 4
Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires the exclusion of all differential diseases
2023 · cited by 0
States that Guillain-Barre syndrome is well appreciated as a peripheral nervous system complication of COVID-19.
See more details
More for · 3
Is the Outcome of Sars-Cov-2 Associated Guillain-Barre Syndrome at Variance Between Rich and Poor?
2022 · cited by 0
Discusses the clinical presentation and management of patients who developed Guillain-Barre syndrome following SARS-CoV-2 infection.
Guillain-Barre Syndrome due to SARS-CoV-2
2021 · cited by 0
Examines cases of Guillain-Barre syndrome directly attributed to SARS-CoV-2 infection.
SARS-CoV-2 associated Guillain-Barre syndrome is immune-mediated rather than infectious
2021 · cited by 0
Notes that SARS-CoV-2 associated Guillain-Barre syndrome occurs, characterizing it as predominantly immune-mediated rather than a direct infectious polyradiculitis.